Total Payments
$752.30
2024 Payments
$60.07
Companies
13
Transactions
24
Medicare Patients
975
Medicare Billing
$118,918
Payment Breakdown by Category
Food & Beverage$752.30 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $752.30 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $136.07 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $134.81 | 2 | $0 (2023) |
| Boston Scientific Corporation | $91.67 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $91.55 | 5 | $0 (2024) |
| BIOTRONIK INC. | $68.85 | 1 | $0 (2023) |
| Lexicon Pharmaceuticals, Inc. | $49.61 | 3 | $0 (2023) |
| PFIZER INC. | $44.45 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $26.85 | 2 | $0 (2023) |
| Amgen Inc. | $26.44 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.30 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.07 | 3 | Kiniksa Pharmaceuticals International, plc ($24.99) |
| 2023 | $692.23 | 21 | Actelion Pharmaceuticals US, Inc. ($136.07) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Not Applicable | ||||||
| 01/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/15/2024 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.76 | General |
| 12/05/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $91.67 | General |
| Category: General - Therapies_CRM | ||||||
| 12/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: DIABETES | ||||||
| 11/21/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiology | ||||||
| 11/15/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 10/19/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $136.07 | General |
| Category: Cardiology | ||||||
| 10/12/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $123.92 | General |
| Category: Cardiovascular | ||||||
| 09/27/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiology | ||||||
| 09/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/07/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 09/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/31/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2023 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device), BIOMONITOR | Food and Beverage | In-kind items and services | $68.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.89 | General |
| Category: Cardiovascular | ||||||
| 06/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 975 | 1,475 | $390,484 | $118,918 |
Total Patients
975
Total Services
1,475
Medicare Billing
$118,918
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 81 | 82 | $75,030 | $25,936 | 34.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 127 | 128 | $55,168 | $17,264 | 31.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 256 | $36,352 | $15,590 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 124 | $25,792 | $11,730 | 45.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 58 | 236 | $28,792 | $8,958 | 31.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 14 | 14 | $18,466 | $8,510 | 46.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $19,520 | $7,357 | 37.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 67 | $18,090 | $6,716 | 37.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 106 | 106 | $13,356 | $5,488 | 41.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 80 | 162 | $80,352 | $5,274 | 6.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 84 | 85 | $12,410 | $3,816 | 30.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 84 | 88 | $2,904 | $893.14 | 30.8% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 12 | 12 | $2,064 | $577.08 | 28.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 20 | 20 | $880.00 | $322.20 | 36.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 14 | 14 | $728.00 | $272.30 | 37.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 20 | 20 | $580.00 | $213.60 | 36.8% |
About Dr. Helge Simon, M.D
Dr. Helge Simon, M.D is a Clinical Cardiac Electrophysiology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639101371.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Helge Simon, M.D has received a total of $752.30 in payments from pharmaceutical and medical device companies, with $60.07 received in 2024. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($752.30).
As a Medicare-enrolled provider, Simon has provided services to 975 Medicare beneficiaries, totaling 1,475 services with total Medicare billing of $118,918. Data is available for 1 year (2023–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Cardiovascular Disease
- Location Toledo, OH
- Active Since 07/06/2006
- Last Updated 06/29/2024
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1639101371
Products in Payments
- ELIQUIS (Drug) $138.78
- UPTRAVI (Drug) $136.07
- Acticor 7 VR-T DX (Device) $68.85
- ENTRESTO (Drug) $54.49
- Inpefa (Drug) $49.61
- LEQVIO (Drug) $37.06
- VYNDAQEL (Drug) $29.59
- XARELTO (Drug) $26.85
- Repatha (Biological) $26.44
- JARDIANCE (Drug) $25.30
- Arcalyst (Drug) $24.99
- CLEVIPREX (Drug) $17.95
- CAMZYOS (Drug) $10.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Cardiac Electrophysiology Doctors in Toledo
Dr. Ryan Cunnane, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $270,588
Clinical Cardiac Electrophysiology $270,588
Timothy Phelan, Md, MD
Clinical Cardiac Electrophysiology — Payments: $14,812
Clinical Cardiac Electrophysiology $14,812
Mark O'connor, Md, MD
Clinical Cardiac Electrophysiology — Payments: $3,285
Clinical Cardiac Electrophysiology $3,285